Shulamit Ron-Bigger, Chief Operating Officer at Aktis Oncology, sold AKTS on Jul 8, 2026
Data as of Oct 16
▼ SELL$429K15,800 shares at $27.13Shulamit Ron-Bigger Chief Operating OfficerAKTS Aktis Oncology, Inc.
- Traded
- Jul 8, 2026
- Disclosed
- Jul 10, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
AKTS since disclosure
−46.0%
after the sale
Similar stocks (XLV) since disclosure
+9.9%
XLV — its sector index fund
Change in closing price from Jul 10, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLShulamit Ron-Bigger Chief Operating OfficerAKTS Aktis Oncology, Inc.$121Kdisclosed Jul 10 · filed 2 days after the trade
- ▼ SELLShulamit Ron-Bigger Chief Operating OfficerAKTS Aktis Oncology, Inc.$838Kdisclosed Jul 10 · filed 2 days after the trade